GGrantIndex
Sort

51,593 grants matching hepatitis

Effect of Dietary Macronutrient Composition and Weight Loss on Liver Substrate Me

$392,500
Elizabeth Jane Parks · Ut Southwestern Medical Center · RL1 · FY2007 · DK

IDU Access to HIV/HCV Prevention

$392,500
Brown University · R01 · FY2002 · DA

Epigenetic Regulation of Mitochondrial Homeostasis and Energy Metabolism

$392,500
Qin Yang · University Of California-Irvine · R01 · FY2021 · DK

Role of Sphingomyelin in Lipoprotein Metabolism

$392,500
Papasani V Subbaiah · University Of Illinois At Chicago · R01 · FY2011 · HL

LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease Modulation

$392,500
David Y Hui · University Of Cincinnati · R01 · FY2011 · DK

Epitranscriptomic regulation of HBV gene expression

$392,500
Aleem Siddiqui · University Of California, San Diego · R56 · FY2018 · AI

Molecular Pharmacology of Insulin Resistance in Burns

$392,499
Jeevendra Martyn · Massachusetts General Hospital · R01 · FY2009 · GM

Redox and Proteomic Stress Responses in Biliary Disease

$392,486
Michael A Pack · University Of Pennsylvania · R01 · FY2024 · DK

Development of liver homing PAR2 pepducins for the treatment of Hepatocellular Carcinoma

$392,485
Athan Kuliopulos · Oasis Pharmaceuticals · R41 · FY2022 · CA

Perinatal Mechanisms of Detoxification

$392,435
Eric F Johnson · Scripps Research Institute, The · R01 · FY2014 · HD

Dissection of Pten-regulated signals in hepatopathogenesis

$392,425
Gen-Sheng Feng · University Of California, San Diego · R01 · FY2019 · CA

Deriving hepatocytes from disease specific iPS to treat metabolic liver disorders

$392,425
Namita Roy-Chowdhury · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · DK

Mechanisms of Hepatocyte Polarization and Apical Tube Formation

$392,386
Erfei Bi · University Of Pennsylvania · R01 · FY2021 · DK

GMPS-GMPR Axis Melanoma Progression and Therapy

$392,357
Mikhail Nikiforov · Duke University · R01 · FY2022 · CA

Characterization of HCV vaccine induced-neutralizing antibody response in non-human primates

$392,336
Pamela J Bjorkman · Johns Hopkins University · U19 · FY2021 · AI

MIF in progression and treatment of ALD

$392,296
Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2013 · AA

In vitro Expression of Hormone Regulated Genes: COUP-TFII in CDH

$392,289
Ming-Jer Tsai · Baylor College Of Medicine · R01 · FY2008 · HD

Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease

$392,288
Philip W Shaul · Ut Southwestern Medical Center · R01 · FY2012 · HL

Regulated Intramembrane Proteolysis of CREB3L1 in Innate Antiviral Response

$392,288
Jin Ye · Ut Southwestern Medical Center · R01 · FY2011 · AI

Gastrointestinal Safety of Antithrombotic Drug Regimens

$392,266
Neena S Abraham · Mayo Clinic Arizona · R01 · FY2018 · HS

Development of an HTS Assay for Discovery of HBV cccDNA Inhibitors

$392,250
Haitao Guo · Indiana University Indianapolis · R01 · FY2018 · AI

Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer

$392,242
Scott Andrew Gerber · University Of Rochester · R01 · FY2023 · CA

Clinical Research on Non-Alcoholic Steatohepatitis

$392,240
Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2004 · DK

Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer

$392,238
Scott Andrew Gerber · University Of Rochester · R01 · FY2022 · CA

Regulation of T helper cell functions by aryl hydrocarbon receptor

$392,229
Deepak Angara Rao · Brigham And Women'S Hospital · R01 · FY2021 · AR